<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Reason for Visit</a></li><li><a href="#id2">Encounter Details</a></li><li><a href="#id3">Social History</a></li><li><a href="#id4">Last Filed Vital Signs</a></li><li><a href="#id5">Progress Notes</a></li><li><a href="#id6">Plan of Treatment</a></li><li><a href="#id7">Results</a></li><li><a href="#id8">Visit Diagnoses</a></li><li><a href="#id9">Care Teams</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Reason for Visit</a></h3><div><ul><li><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Reason</th><th>Comments</th></tr></thead><tbody><tr ID="rfv2"><td ID="reasonrfv2">Follow-up</td><td/></tr></tbody></table></li></ul></div><h3><a name="id2" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter3" class="xRowNormal"><td>[REDACTED]  9:30 AM EDT</td><td ID="encounter3type">Office Visit</td><td><p>Cancer Center of [REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]-3443</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>Ste 101A</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td><span class="content_span">Prostate cancer (HC CODE) (Primary Dx)</span></td></tr></tbody></table></div><h3><a name="id3" href="#toc">Social History</a></h3><div><table ID="sochist8"><colgroup><col width="25%" span="2"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Never</td><td/><td ID="sochist8packsperday"/><td/><td/></tr><tr ID="sochist8smokeless" class="xRowAlt"><td>Smokeless Tobacco: Never</td><td/><td/><td/><td/></tr></tbody></table><table><colgroup><col width="25%" span="2"/><col width="50%"/></colgroup><thead><tr><th>Alcohol Use</th><th>Standard Drinks/Week</th><th>Comments</th></tr></thead><tbody><tr><td ID="alcoholStatus">Yes</td><td>0 (1 standard drink = 0.6 oz pure alcohol)</td><td>2 beers per week</td></tr></tbody></table><table><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex12"><td>Sex Assigned at Birth</td><td ID="BirthSex12Value">Not on file</td><td/></tr><tr ID="LegalSex13"><td>Legal Sex</td><td ID="LegalSex13Value">Male</td><td>[REDACTED]  8:38 AM EST</td></tr><tr ID="GenderIdentity9"><td>Gender Identity</td><td ID="GenderIdentity9Value">Not on file</td><td/></tr><tr ID="SexualOrientation10"><td>Sexual Orientation</td><td ID="SexualOrientation10Value">Not on file</td><td/></tr></tbody></table><table><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Travel History</th><th>Travel Start</th><th>Travel End</th></tr></thead><tbody><tr><td ID="sochist11">[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id4" href="#toc">Last Filed Vital Signs</a></h3><div><table><colgroup><col width="25%" span="4"/></colgroup><thead><tr><th>Vital Sign</th><th>Reading</th><th>Time Taken</th><th>Comments</th></tr></thead><tbody><tr class="xRowNormal"><td class="xcellHeader">Blood Pressure</td><td><span class="content_span">148</span>/<span class="content_span">57</span></td><td>[REDACTED]  9:29 AM EDT</td><td/></tr><tr ID="pulse_5718259740" class="xRowAlt"><td class="xcellHeader">Pulse</td><td>60</td><td>[REDACTED]  9:29 AM EDT</td><td/></tr><tr ID="temp_5718259740" class="xRowNormal"><td class="xcellHeader">Temperature</td><td>35.8 °C (96.5 °F)</td><td>[REDACTED]  9:29 AM EDT</td><td/></tr><tr ID="resp_5718259740" class="xRowAlt"><td class="xcellHeader">Respiratory Rate</td><td>17</td><td>[REDACTED]  9:29 AM EDT</td><td/></tr><tr ID="SpO2_5718259740" class="xRowNormal"><td class="xcellHeader">Oxygen Saturation</td><td>96%</td><td>[REDACTED]  9:29 AM EDT</td><td/></tr><tr ID="inhaled_" class="xRowAlt"><td class="xcellHeader">Inhaled Oxygen Concentration</td><td>-</td><td>-</td><td/></tr><tr ID="weight_5718259740" class="xRowNormal"><td class="xcellHeader">Weight</td><td>96.3 kg (212 lb 6.4 oz)</td><td>[REDACTED]  9:29 AM EDT</td><td/></tr><tr ID="height_5718259740" class="xRowAlt"><td class="xcellHeader">Height</td><td>177.8 cm (5' 10")</td><td>[REDACTED]  9:29 AM EDT</td><td/></tr><tr ID="bmi_5718259740" class="xRowNormal"><td class="xcellHeader">Body Mass Index</td><td>30.48</td><td>[REDACTED]  9:29 AM EDT</td><td/></tr></tbody></table>documented in this encounter</div><h3><a name="id5" href="#toc">Progress Notes</a></h3><div><ul><li>[REDACTED], MD - [REDACTED]  9:30 AM EDT: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/><span class="xLabel">Images from the original note were not included.</span><br/><br/>Patient: [REDACTED]  <br/>MR Number: 101059036 <br/>Date of Birth:  [REDACTED]  <br/>Date of Visit:  [REDACTED]  <br/><br/>Chief Complaint <br/>Patient presents with <br/>• Follow-up <br/><br/>HPI<br/>[REDACTED] is a [REDACTED]. male with a PSA ranging from 3-3.4, per his report, who was found to have a nodule on DRE and biopsy revealed a [REDACTED] 7 (3+4) prostate cancer diagnosed in 11/2020. Detailed Hem/Onc history is as below.<br/>.<br/>HEM/ONC HX:<br/>[REDACTED]-[REDACTED] - PSA ranging from 3-3.4, per pt report<br/>11/2020 - [REDACTED] noted on DRE with [REDACTED]<br/>[REDACTED] - MRI pelvis w/ and w/o (DCA) - BPH type pattern with 2 lesion suspected to represent high grade malignancy in left peripheral zone, PI-RADS 5.<br/>[REDACTED] - U/S-guided prostate biopsies (JMC / [REDACTED]) - 1 core biopsy with 3+4 = [REDACTED] 7 prostate adenocarcinoma, 3 cores with 3+3 = [REDACTED] 6 for a total of 4/13 cores positive for adenocarcinoma<br/>[REDACTED] - Glucose 146, rest of cbc/CMP unremarkable<br/>[REDACTED] - Bone scan (JMC) - abnormal uptake about the right sacrum suspicious for infiltrative disease<br/>[REDACTED] - MRI pelvis w/o contrast (JMC) - no T1 hypointense geographic lesions in the right sacrum corresponding to findings on bone scan<br/>[REDACTED] - Appt with Rad Onc ([REDACTED]) - plan to proceed with IMRT for a total dose of 79-80 grey over 8-9 weeks<br/>[REDACTED] - Initial evaluation in our office<br/>[REDACTED] - Loading dose Firmagon given<br/>[REDACTED] - Monthly Firmagon given. Continues on IMRT with [REDACTED]<br/>[REDACTED] - PSA 2.71<br/>[REDACTED] - PSA 0.23<br/>[REDACTED] - Patient states he completed IMRT with [REDACTED]<br/>[REDACTED] - PSA 0.05<br/>[REDACTED] - 6th dose of monthly Firmagon given<br/>[REDACTED] - PSA undetectable, testosterone 17<br/>[REDACTED] - PSA 0.03, testosterone 46<br/>[REDACTED] - PSA 0.03, testosterone 52.6<br/>[REDACTED] - PSA 0.09<br/>01/2022 - PET/CT - within normal limits.  No evidence of PET abnormality<br/>01/2022 - PSA 0.09<br/>03/2022 - PSA 0.07, testosterone 153<br/><br/>INTERIM HISTORY<br/>[REDACTED] returns to clinic [REDACTED] for ongoing followup and management.  He is clinically doing well.  He has no new complaints.  His energy, activity level and functional status are all improving as his testosterone has been slowly going back to his baseline.  <br/><br/>Current Medications  <br/>   Dosage <br/> aspirin EC 81 mg EC tablet (Taking) Take 162 mg by mouth.  <br/> atorvastatin (LIPITOR) 40 mg tablet (Taking)  <br/> cholecalciferol, vitamin D3, 25 mcg (1,000 unit) Cap (Taking) Take 1,000 Units by mouth. <br/> losartan-hydrochlorothiazide (HYZAAR) 100-12.5 mg per tablet (Taking)  <br/> metFORMIN (GLUCOPHAGE) 500 mg tablet (Taking)  <br/> metoprolol tartrate (LOPRESSOR) 50 mg tablet (Taking)  <br/> Jardiance 10 mg Tab  <br/> <br/> <br/><br/>Allergies <br/>Allergen Reactions <br/>• Penicillins Rash and Unknown <br/> <br/><br/>Past Medical History: <br/>Diagnosis Date <br/>• CAD (coronary artery disease)  <br/>• Diabetes mellitus (HC CODE)  <br/>• High cholesterol  <br/>• Hypertension  <br/>• Tachycardia  <br/><br/>Past Surgical History: <br/>Procedure Laterality Date <br/>• FRACTURE SURGERY   <br/> <br/><br/>Family History <br/>Problem Relation Age of Onset <br/>• Multiple Sclerosis Son  <br/> <br/><br/>Social History <br/><br/>Tobacco Use <br/>• Smoking status: Never Smoker <br/>• Smokeless tobacco: Never Used <br/>Substance Use Topics <br/>• Alcohol use: Yes <br/>  Comment: 2 beers per week <br/>• Drug use: Not on file <br/> <br/><br/>Review of Systems <br/>Constitutional: <br/>     As per hem/onc hx <br/>HENT: Negative.  <br/>Eyes: Negative.  <br/>Respiratory: Negative.  <br/>Cardiovascular: Negative.  <br/>Gastrointestinal: Negative.  <br/>Genitourinary: Negative.  <br/>Musculoskeletal: <br/>     As per hem/onc hx <br/>Skin: Negative.  <br/>Neurological: Negative.  <br/>Endo/Heme/Allergies: Negative.  <br/>Psychiatric/Behavioral: Negative.  <br/><br/>Vitals: <br/> [REDACTED] 0929 <br/>BP: 148/57 <br/>Pulse: 60 <br/>Resp: 17 <br/>Temp: 96.5 °F (35.8 °C) <br/> <br/>Body mass index is 30.48 kg/m².<br/><br/>Physical Exam<br/>GENERAL APPEARANCE: no acute distress <br/>EYES: conjunctiva and lids normal, PERRLA<br/>ORAL CAVITY: oral exam WNL<br/>NECK/THYROID: supple, no JVD<br/>LYMPH NODES: no anterior or posterior cervical, supraclavicular, or axillary adenopathy<br/>SKIN: no acute rashes or ulcerations<br/>HEART: regular rate and rhythm<br/>LUNGS: clear to auscultation bilaterally<br/>CHEST: no masses, tenderness; no asymmetry<br/>ABDOMEN: soft, nontender; no hepatosplenomegaly, masses; active bowel sounds, no rigidity<br/>MUSCULOSKELETAL: left hip flexion and extension 4/5, left lower leg flexion and extension 4/5, right 5/5<br/>EXTREMITIES: no clubbing, cyanosis<br/>NEUROLOGIC: normal mental status, CN 2-12 grossly intact<br/>PSYCH: alert; oriented to person, place, and time <br/> <br/><br/>DIAGNOSES<br/>1. Prostate cancer (HC Code)  POCT AMB CBC (SYSMEX) at [REDACTED] <br/> COMPREHENSIVE METABOLIC PANEL (CMP), SERUM <br/> PROSTATE SPECIFIC ANTIGEN (PSA) <br/> TESTOSTERONE <br/> <br/><br/>ASSESSMENT/PLAN <br/>A [REDACTED]. male with prostate cancer, [REDACTED] 7 (3+4) in 1 core and [REDACTED] 6 (3+3) in 3 cores on 11/2020 biopsies, status post IMRT as well as 6 months of Firmagon, off of therapy, now on surveillance, who is clinically doing well with the exception of new onset back pain which he thinks might be mechanical in nature but is eating well and has good energy.  His previous scans and PSA are all reassuring, and his most recent level of 0.07 indicated no evidence of recurrent disease biochemically.<br/><br/>We will see him back to clinic at 3 month intervals.  He will call us sooner if issues arise.  We will recheck his PSA and will continue to monitor him.  He is otherwise in good spirits and is having an excellent PSA response.  We will get a PSA [REDACTED] and then discuss repeat imaging only if his PSA starts to rise.<br/><br/>Total time spent face to face was 20 minutes, out of which more than 50 percent of the time was spent counseling the above and coordinating care. <br/><br/>cc: [REDACTED], [REDACTED], [REDACTED]<br/><br/>Return in about 3 months (around [REDACTED]). <br/><br/>tcl<br/><br/></content><br/><span class="xLabel">Electronically signed by [REDACTED] at [REDACTED] 11:44 AM EDT</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id6" href="#toc">Plan of Treatment</a></h3><div><table><span style="font-weight:bold; ">Scheduled Orders</span><colgroup><col width="25%"/><col width="15%"/><col width="10%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Name</th><th>Type</th><th>Priority</th><th>Associated Diagnoses</th><th>Order Schedule</th></tr></thead><tbody><tr ID="procedure33"><td><span class="content_span">POCT AMB CBC (SYSMEX) at CCSF [REDACTED]</span></td><td>Point of Care Testing</td><td>Routine</td><td><p>Prostate cancer (HC CODE)</p></td><td ID="procedure33schedule">Ordered: [REDACTED]</td></tr><tr ID="procedure34"><td><span class="content_span">TESTOSTERONE</span></td><td>Lab</td><td>Routine</td><td><p>Prostate cancer (HC CODE)</p></td><td ID="procedure34schedule">Expected: [REDACTED] (Approximate), Expires: [REDACTED]</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id7" href="#toc">Results</a></h3><div><ul><li>PROSTATE SPECIFIC ANTIGEN (PSA) ([REDACTED] 12:17 PM EDT): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col width="10%" span="2"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634199.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634199.Comp1Name">PROST. SPECIFIC AG</td><td><span class="content_span">0.09</span></td><td>&lt; OR = 4.00 ng/mL</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634199.Comp1Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><br/><content class="xpre">The total PSA value from this assay system is <br/>standardized against the WHO standard. The test <br/>result will be approximately 20% lower when compared <br/>to the equimolar-standardized total PSA ([REDACTED] <br/>[REDACTED]). Comparison of serial PSA results should be <br/>interpreted with this fact in mind.<br/> <br/>This test was performed using the Siemens <br/>chemiluminescent method. Values obtained from <br/>different assay methods cannot be used<br/>interchangeably. PSA levels, regardless of<br/>value, should not be interpreted as absolute<br/>evidence of the presence or absence of disease.<br/> <br/></content></content></td></tr></tbody></table><table><colgroup><col width="20%" span="5"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634199.Specimen">Blood</td><td/><td/><td>[REDACTED] 12:17 PM EDT</td><td>[REDACTED] 12:20 AM EDT</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p/></td></tr></tbody></table><table><thead><tr><th>Resulting Agency Comment</th></tr></thead><tbody><tr><td class="xpre"><p><span class="content_span">Performing Organization Information:</span><br/><span class="content_span">    Site ID: MI</span><br/><span class="content_span">    Name: Quest Diagnostics-[REDACTED]</span><br/><span class="content_span">    Address: [REDACTED][REDACTED]</span><br/><span class="content_span">    Director: [REDACTED]</span></p></td></tr></tbody></table><table><colgroup><col width="20%" span="2"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>[REDACTED] MD</td><td>LAB BLOOD ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col width="20%" span="3"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634199.PerformingLab"><p>QUEST</p></td><td><p>[REDACTED][REDACTED]</p></td><td><p>[REDACTED], FL 33617, [REDACTED]</p></td><td><p/></td></tr></tbody></table></li><li>(ABNORMAL) COMPREHENSIVE METABOLIC PANEL (CMP), SERUM ([REDACTED] 12:17 PM EDT): <table><colgroup><col width="20%"/><col width="12%"/><col width="8%"/><col width="20%"/><col width="10%" span="2"/><col width="20%"/></colgroup><thead><tr><th>Component</th><th>Value</th><th>Ref Range</th><th>Test Method</th><th>Analysis Time</th><th>Performed At</th><th>Pathologist Signature</th></tr></thead><tbody><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp1" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp1Name">Glucose</td><td><span class="xflagData">123</span><span class="xflagData"> (H)</span></td><td>65 - 99 mg/dL</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp1Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><br/><content class="xpre"> <br/>           Fasting reference interval<br/> <br/>For someone without known diabetes, a glucose value<br/>between 100 and 125 mg/dL is consistent with<br/>prediabetes and should be confirmed with a<br/>follow-up test.<br/> <br/> <br/></content></content></td></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp2" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp2Name">BUN</td><td>17</td><td>7 - 25 mg/dL</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp2Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp3" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp3Name">CREATININE,BLOOD</td><td><span class="content_span">0.97</span></td><td>0.70 - 1.18 mg/dL</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp3Signature"/></tr><tr class="xRowNormal xmergeUp"><td colspan="7"><content class="xallIndent"><span class="xcellHeader">Comment: </span><br/><content class="xpre">For patients &gt;49 years of age, the reference limit<br/>for Creatinine is approximately 13% higher for people<br/>identified as African-American.<br/> <br/> <br/></content></content></td></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp4" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp4Name">eGFR Non-African American</td><td>74</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp4Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp5" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp5Name">eGFR African American</td><td>86</td><td>&gt; OR = 60 mL/min/1.73m2</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp5Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp6" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp6Name">BUN / CREAT RATIO</td><td>NOT APPLICABLE</td><td>6 - 22 (calc)</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp6Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp7" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp7Name">Sodium</td><td>140</td><td>135 - 146 mmol/L</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp7Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp8" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp8Name">Potassium</td><td>4.5</td><td>3.5 - 5.3 mmol/L</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp8Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp9" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp9Name">Chloride</td><td>101</td><td>98 - 110 mmol/L</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp9Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp10" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp10Name">CO2</td><td>30</td><td>20 - 32 mmol/L</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp10Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp11" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp11Name">CALCIUM</td><td>9.8</td><td>8.6 - 10.3 mg/dL</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp11Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp12" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp12Name">TOTAL PROTEIN</td><td>6.9</td><td>6.1 - 8.1 g/dL</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp12Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp13" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp13Name">ALBUMIN</td><td>4.5</td><td>3.6 - 5.1 g/dL</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp13Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp14" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp14Name">GLOBULIN</td><td>2.4</td><td>1.9 - 3.7 g/dL (calc)</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp14Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp15" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp15Name">A/G RATIO</td><td>1.9</td><td>1.0 - 2.5 (calc)</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp15Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp16" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp16Name">TOTAL BILIRUBIN</td><td>0.7</td><td>0.2 - 1.2 mg/dL</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp16Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp17" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp17Name">ALKALINE PHOSPHATASE</td><td>59</td><td>35 - 144 U/L</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp17Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp18" class="xRowAlt"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp18Name">AST (SGOT)</td><td>20</td><td>10 - 35 U/L</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp18Signature"/></tr><tr ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp19" class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp19Name">ALT (SGPT)</td><td>25</td><td>9 - 46 U/L</td><td/><td/><td>QUEST</td><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Comp19Signature"/></tr></tbody></table><table><colgroup><col width="20%" span="5"/></colgroup><thead><tr><th>Specimen (Source)</th><th>Anatomical Location / Laterality</th><th>Collection Method / Volume</th><th>Collection Time</th><th>Received Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.Specimen">Blood</td><td/><td/><td>[REDACTED] 12:17 PM EDT</td><td>[REDACTED] 12:20 AM EDT</td></tr></tbody></table><table><thead><tr><th>Narrative</th></tr></thead><tbody><tr><td class="xpre"><p/></td></tr></tbody></table><table><thead><tr><th>Resulting Agency Comment</th></tr></thead><tbody><tr><td class="xpre"><p><span class="content_span">Performing Organization Information:</span><br/><span class="content_span">    Site ID: MI</span><br/><span class="content_span">    Name: Quest Diagnostics-[REDACTED]</span><br/><span class="content_span">    Address: [REDACTED][REDACTED]</span><br/><span class="content_span">    Director: [REDACTED]</span></p></td></tr></tbody></table><table><colgroup><col width="20%" span="2"/><col width="60%"/></colgroup><thead><tr><th>Authorizing Provider</th><th>Result Type</th><th>Result Status</th></tr></thead><tbody><tr><td>[REDACTED] MD</td><td>LAB BLOOD ORDERABLES</td><td>Final Result</td></tr></tbody></table><table><colgroup><col width="20%" span="3"/><col width="40%"/></colgroup><thead><tr><th>Performing Organization</th><th>Address</th><th>City/State/ZIP Code</th><th>Phone Number</th></tr></thead><tbody><tr><td ID="Result.1.2.840.114350.1.13.259.2.7.2.798268.286634200.PerformingLab"><p>QUEST</p></td><td><p>[REDACTED][REDACTED]</p></td><td><p>[REDACTED][REDACTED][REDACTED]</p></td><td><p/></td></tr></tbody></table></li></ul>documented in this encounter</div><h3><a name="id8" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx4" class="xRowNormal"><td><p><span class="content_span">Prostate cancer (HC CODE)</span><span class="content_span"> - Primary</span></p><p>Malignant neoplasm of prostate</p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id9" href="#toc">Care Teams</a></h3><div><table ID="ct44"><colgroup><col width="25%" span="3"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>[REDACTED], MD</p><p>NPI: [REDACTED]</p><p>[REDACTED]</p><p>STE 400</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td/><td>Internal Medicine</td><td>[REDACTED]</td><td/></tr><tr class="xRowAlt"><td><p>[REDACTED], MD</p><p>NPI: [REDACTED]</p><p>[REDACTED][REDACTED]</p><p>STE 104</p><p>JUPITER, FL 33458</p><p>[REDACTED] (Work)</p></td><td/><td>Urology</td><td>[REDACTED]</td><td/></tr><tr class="xRowNormal"><td><p>[REDACTED], MD</p><p>NPI: [REDACTED]</p><p>1094 MILITARY TRL</p><p>JUPITER, FL 33458</p><p>[REDACTED] (Work)</p></td><td/><td>Diagnostic Radiology</td><td>[REDACTED]</td><td>[REDACTED]</td></tr></tbody></table>documented as of this encounter</div><br/><br/>
</body></html>